Explore the iShares Biotechnology ETF and iShares U.S. Healthcare ETF for targeted exposure to U.S. biotech companies and broad healthcare diversification respectively.
TL/DR -
A recent survey by PhRMA reveals that having health insurance doesn't always guarantee optimal healthcare outcomes for Americans with concerns about out-of-pocket costs and access to necessary medications being identified as significant barriers. Forty percent of insured adults reported postponing medical treatment due to cost, and 38% of…